$AVXL
Anavex Life Sciences Corp.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
AVXL chart
What traders are saying about $AVXL
Latest postsAnavex Life Sciences Corp. news
- What's Next for Anavex Life Sciences Corp. Shareholders After 6.35% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
PR Newswire ·
- Anavex Life Sciences Corp (12X1.DU) Seasonal returns chart
Yahoo Finance UK ·
- AVXL FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL,
GlobeNewswire ·
- Form 4 Anavex Life Sciences Corp: Claus Vander Velden (Director) For: 3 November
Investing.com Canada ·
- Director receives 50,000 Anavex (AVXL) options with a $1.20 exercise price.
Stock Titan ·
- Anavex Life Sciences Stock Price Forecast. Should You Buy AVXL?
StockInvest.us ·
- Anavex Life Sciences Corp. (AVXL) Seasonal returns chart
Yahoo Finance Australia ·
- What Does Anavex Life Sciences Corp.'s 6.35% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff Deadline
Eastern Progress ·
- Anavex Life Sciences Corp. Investors Seeking Lead Plaintiff
GlobeNewswire ·
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
PR Newswire ·
- What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
PR Newswire ·
- SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC
GlobeNewswire ·
Anavex Life Sciences Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$46.4M | -$43.0M | -$47.5M | -$48.0M |
| Diluted EPS | $-0.54 | $-0.52 | $-0.60 | $-0.62 |
| Total assets (year end) | $133.0M | $124.0M | $148.1M | $148.4M |
| Cash and equivalents (year end) | $131.7M | $120.8M | $143.8M | $143.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Anavex Life Sciences Corp.
- Ticker
- AVXL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Fiscal year end
- September 30
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc.
Frequently asked questions
What exchange is Anavex Life Sciences Corp. listed on?
Anavex Life Sciences Corp. trades on the Nasdaq under the ticker symbol AVXL.
What industry is Anavex Life Sciences Corp. in?
Anavex Life Sciences Corp. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Anavex Life Sciences Corp. headquartered?
Anavex Life Sciences Corp.'s business address on file with the SEC is in New York, NY.
When does Anavex Life Sciences Corp.'s fiscal year end?
Anavex Life Sciences Corp.'s fiscal year ends on September 30.